Haemonetics Corporation
HAE
$121.62-0.36%
End of day · as of Oct 14, 2026, 2:00 AM ET
Mkt cap
$3.24B
EV/Sales
N/A
P/E ratio
N/A
FY2026 Revenue
$1.33B
EPS (9mo ended 2025-12-27)
$2.46
Gross Margin (FY2026)
59.04%
Profit Margin (FY2026)
7.29%
Beta
0.54
Div yield
N/A
Sector
Healthcare
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B.
Use this HAE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full HAE income, balance, and cash tables.
Haemonetics Corporation (HAE) is a medical devices company in the Healthcare sector.
Latest cached Haemonetics Corporation (HAE) revenue for Mar 28, 2026 was $1.33B. Net income was $97.3M. Statements: https://lician.com/financials/hae
Haemonetics Corporation (HAE) market capitalization is $3.24B on the latest cached snapshot.
Haemonetics Corporation (HAE) cached previous close $122.06; day range $121.59 – $122.80; volume 684,075. Session quote: https://lician.com/quote/hae
Haemonetics Corporation (HAE) latest cached earnings event is "HAE earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached HAE filing is 8-K · Oct 8, 2026. Filings: https://lician.com/sec/hae